Blonna Davide, Huffmann G Russell, O'Driscoll Shawn W
Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA Department of Orthopaedics and Traumatology, University of Turin Medical School, Turin, Italy.
Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA Department of Orthopaedic Surgery, Penn Sports Medicine Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Am J Sports Med. 2014 Sep;42(9):2113-21. doi: 10.1177/0363546514540448. Epub 2014 Jul 11.
Little information exists regarding delayed-onset ulnar neuritis (DOUN) after arthroscopic release of elbow contractures.
To describe, in a large cohort of patients, the clinical presentation of and risk factors for developing DOUN after arthroscopic release of elbow contractures.
Case-control study; Level of evidence, 3.
A retrospective study of 565 consecutive arthroscopic releases of elbow contractures was conducted. Essentially, DOUN was defined as ulnar neuritis or neuropathy, or worsening of pre-existing ulnar nerve symptoms, that developed postoperatively in patients with normal neurological examination findings immediately after surgery. After inclusion and exclusion criteria were met, 235 contracture releases in patients who had not undergone any ulnar nerve surgery remained and were used for the analysis of risk factors with a multivariate logistic regression analysis.
Twenty-six patients (11%) developed DOUN. The patients fell into 1 of 3 distinct groups. Fifteen (58%) presented with rapidly progressive DOUN, characterized by rapidly progressive sensorimotor ulnar neuropathy, increasing pain at the cubital tunnel during end-range flexion and/or extension, and rapidly deteriorating range of motion within the first week after surgery. Urgent ulnar subcutaneous nerve transposition was performed within 1 or 2 days of diagnosis. Eight (31%) presented with nonprogressive DOUN, characterized by mild sensory ulnar neuropathy, neither motor weakness nor substantial pain at the cubital tunnel, or loss of motion. Three (12%) presented with slowly progressive DOUN, characterized by the insidious onset of mild ulnar neuropathy. Significant risk factors for DOUN included a diagnosis of heterotopic ossification (odds ratio, 31; 95% CI, 5-191; P < .001), preoperative neurological symptoms (odds ratio, 6; 95% CI, 2-19; P = .001), and preoperative arc of motion (odds ratio, 0.97 per degree of motion; 95% CI, 0.96-0.99; P = .02).
Delayed-onset ulnar neuritis is an important complication of arthroscopic release of elbow contractures. We recommend a high index of suspicion and monitoring patients with progressive loss of elbow motion and end-range pain for evidence of subclinical ulnar neuritis.
关于肘关节挛缩关节镜松解术后迟发性尺神经炎(DOUN)的信息较少。
在一大群患者中描述肘关节挛缩关节镜松解术后发生DOUN的临床表现及危险因素。
病例对照研究;证据等级,3级。
对连续565例肘关节挛缩关节镜松解术进行回顾性研究。本质上,DOUN被定义为在术后立即进行的神经系统检查结果正常的患者中,术后出现的尺神经炎或神经病变,或既往尺神经症状的恶化。在满足纳入和排除标准后,对未接受任何尺神经手术的患者的235例挛缩松解术进行分析,采用多因素逻辑回归分析危险因素。
26例患者(11%)发生DOUN。这些患者分为3个不同的组。15例(58%)表现为快速进展性DOUN,其特征为快速进展的感觉运动性尺神经病变、终末屈伸时肘管处疼痛加剧,以及术后第一周内活动范围迅速恶化。在诊断后1或2天内进行了紧急尺神经皮下移位术。8例(31%)表现为非进展性DOUN,其特征为轻度感觉性尺神经病变,无运动无力,肘管处无明显疼痛或活动丧失。3例(12%)表现为缓慢进展性DOUN,其特征为轻度尺神经病变隐匿起病。DOUN的显著危险因素包括异位骨化诊断(比值比,31;95%可信区间,5 - 191;P < .001)、术前神经症状(比值比,6;95%可信区间,2 - 19;P = .001)和术前活动弧(比值比,每度活动0.97;95%可信区间,0.96 - 0.99;P = .02)。
迟发性尺神经炎是肘关节挛缩关节镜松解术的重要并发症。我们建议高度怀疑,并监测肘关节活动逐渐丧失和终末疼痛的患者是否有亚临床尺神经炎的证据。